Clinical trial
3TC or No 3TC for HIV With 3TC Resistance
NCT00143728 · University of British Columbia, Other · Suspended
Key facts
| NCT number | NCT00143728 |
|---|---|
| Title | 3TC or No 3TC for HIV With 3TC Resistance |
| Official title | A Randomized Study to Evaluate Virologic Response Following Discontinuation vs. no Discontinuation of 3TC in Patients Who Are Infected With HIV With Previously Documented Reduced Susceptibility to 3TC and Who Have Adequate Virologic Suppression on Combination Antiretroviral Therapy |
| Lead sponsor | University of British Columbia, Other |
| Collaborators | CIHR Canadian HIV Trials Network |
| Status | Suspended |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Lamivudine |
| Enrollment | 152 |
| Start date | Jan 1, 2004 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Sep 2, 2005 |
| Last update posted | Sep 25, 2008 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: